ClaryD, Van de BusscheT, JanisM, GossipM. The big chill. Air Med J, 2010; 29:28–31.
2.
DeckardME. Administering medications during targeted temperature management. Crit Care Nurse, 2016; 36:84–85.
3.
GraffagninoC, ErlingeD, KeebleT, NicholG. Current advances in the use of therapeutic hypothermia. Ther Hypothermia Temp Manag, 2015; 5:9–12.
4.
IslamS, Hampton-TillJ, MohdNazriS, WatsonN, GuddeE, GuddeT, KellyPA, TangKH, DaviesJR, KeebleTR. Setting up an efficient therapeutic hypothermia team in conscious ST elevation myocardial infarction patients: A UK heart attack center experience. Ther Hypothermia Temp Manag, 2015; 5:217–22.
5.
IslamS, Hampton-TillJ, WatsonN, MannakkaraNN, HamarnehA, WebberT, MageeN, AbbeyL, JagathesanR, KabirA, SayerJ, RobinsonN, AggarwalR, CleshamG, KellyP, GammaR, TangK, DaviesJR, KeebleTR. Early targeted brain COOLing in the cardiac CATHeterisation laboratory following cardiac arrest (COOLCATH). Resuscitation, 2015; 97:61–67.
6.
KontosMC, OrnatoJP, KurzMC, RobertsCS, GossipM, DhindsaHS, ReidRD, PeberdyMA. Prevalence of troponin elevations in patients with cardiac arrest and implications for assessing quality of care in hypothermia centers. Am J Cardiol, 2013; 112:933–937.
7.
MohdnazriSR, KaramasisGV, Al-JanabiF, CookCM, Hampton-TillJ, ZhangJ, Al-LameeR, DunguJN, GedelaS, TangKH, KellyPA, DaviesJE, DaviesJR, KeebleTR. The impact of coronary chronic total occlusion percutaneous coronary intervention upon donor vessel fractional flow reserve and instantaneous wave-free ratio: Implications for physiology-guided PCI in patients with CTO. Catheter Cardiovasc Interv, 2018 [Epub ahead of print]; DOI: 10.1002/ccd.27587.
8.
NocM, ErlingeD, NeskovicAN, KafedzicS, MerkelyB, ZimaE, FisterM, PetrovićM, ČankovićM, VeressG, LaanmetsP, PernT, VukcevicV, DedovicV, ŚredniawaB, ŚwiątkowskiA, KeebleTR, DaviesJR, WarenitsAM, OlivecronaG, PerugaJZ, CiszewskiM, HorvathI, EdesI, NagyGG, AradiD, HolzerM. COOL AMI EU pilot trial: A multicentre, prospective, randomised controlled trial to assess cooling as an adjunctive therapy to percutaneous intervention in patients with acute myocardial infarction. EuroIntervention, 2017; 13:e531–e539.
9.
PoldermanK, MalinoskiD, TimermanS, KeebleT. Current advances in the use of therapeutic hypothermia. Ther Hypothermia Temp Manag, 2018; 8:9–13.
10.
SawyerKN, KurzMC, ElswickRKJr.; Virginia Commonwealth University ARCTIC Investigators. An investigation of a hypothermic to ischemic ratio in patients following out-of-hospital cardiac arrest presenting with a shockable rhythm. Ther Hypothermia Temp Manag, 2014; 4:72–78.
11.
WatsonN, PotterM, KaramasisG, DamianM, PottingerR, CleshamG, GammaR, AggarwalR, SayerJ, RobinsonN, JagathesanR, KabirA, TangK, KellyP, MaccaroniM, KadayamR, NalgirkarR, NamjoshiG, UroviS, PaiA, WaghmareK, CarusoV, Hampton-TillJ, NocM, DaviesJR, KeebleTR. Is it feasible and safe to wake cardiac arrest patients receiving mild therapeutic hypothermia after 12 hours to enable early neuro-prognostication? The therapeutic hypothermia and early waking trial protocol. Ther Hypothermia Temp Manag, 2018; 8:150–155.